AstraZeneca (AZN), Abbott (ABT) to Develop Diagnostic Tests for Asthma Patients – StreetInsider.com

AstraZeneca (AZN), Abbott (ABT) to Develop Diagnostic Tests for Asthma Patients
StreetInsider.com
AstraZeneca (NYSE: AZN) announced that it has entered an agreement with Abbott (NYSE: ABT), a global healthcare company, to develop companion diagnostic tests to identify patients with severe asthma who are most likely to benefit from the …
AstraZeneca Enters Companion Diagnostic Test Deal With AbbottLondon South East

all 3 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.